BCD With or Without Doxycycline in Mayo Stage II-III Light Chain Amyloidosis Patients

NCT03401372 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Amyloidosis; Systemic

Interventions

DRUG: Doxycycline
DRUG: Bortezomib
DRUG: Cyclophosphamide
DRUG: Dexamethasone

Sponsor

Jian Li

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]